{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PCI&page=7", "query": { "intervention": "PCI", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 563, "total_pages": 57, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PCI&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PCI&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T06:51:29.584Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00165035", "title": "Cobalt Chromium Stent With Antiproliferative for Restenosis II Trial (COSTAR II)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Coronary Disease" ], "interventions": [ { "name": "CoStar Paclitaxel Drug Eluting Coronary Stent System", "type": "DEVICE" }, { "name": "TAXUS™ Express2™ Paclitaxel-Eluting Coronary Stent", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Cordis US Corp.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1701, "start_date": "2005-05", "completion_date": "2011-07", "has_results": false, "last_update_posted_date": "2011-08-04", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 2, "location_summary": "Durham, North Carolina • Cincinnati, Ohio", "locations": [ { "city": "Durham", "state": "North Carolina" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00165035" }, { "nct_id": "NCT04221815", "title": "IMPact on Revascularization Outcomes of IVUS Guided Treatment of Complex Lesions and Economic Impact", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "Eagle Eye Platinum digital IVUS catheter with optional SyncVision", "type": "DEVICE" }, { "name": "Resolute Onyx Drug Eluting Stent", "type": "DEVICE" }, { "name": "Onyx Frontier Drug Eluting Stent", "type": "DEVICE" }, { "name": "Onyx TruStar Drug Eluting Stent", "type": "DEVICE" }, { "name": "Onyx TruCor Drug Eluting Stent", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medstar Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3100, "start_date": "2020-10-14", "completion_date": "2027-09", "has_results": false, "last_update_posted_date": "2025-09-12", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 40, "location_summary": "Tucson, Arizona • Little Rock, Arkansas • La Jolla, California + 36 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "La Jolla", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04221815" }, { "nct_id": "NCT02072421", "title": "The MASS COMM Post-Randomization Phase Cohort Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "PCI", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Baim Institute for Clinical Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2879, "start_date": "2011-10", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2015-04-07", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 10, "location_summary": "Brockton, Massachusetts • Framingham, Massachusetts • Lawrence, Massachusetts + 5 more", "locations": [ { "city": "Brockton", "state": "Massachusetts" }, { "city": "Brockton", "state": "Massachusetts" }, { "city": "Framingham", "state": "Massachusetts" }, { "city": "Lawrence", "state": "Massachusetts" }, { "city": "Lowell", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02072421" }, { "nct_id": "NCT01830543", "title": "A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atrial Fibrillation", "Percutaneous Coronary Intervention" ], "interventions": [ { "name": "rivaroxaban 2.5 mg", "type": "DRUG" }, { "name": "rivaroxaban 15 mg", "type": "DRUG" }, { "name": "rivaroxaban 10 mg", "type": "DRUG" }, { "name": "aspirin (ASA)", "type": "DRUG" }, { "name": "vitamin K antagonist (VKA)", "type": "DRUG" }, { "name": "clopidogrel", "type": "DRUG" }, { "name": "prasugrel", "type": "DRUG" }, { "name": "ticagrelor", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Scientific Affairs, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2124, "start_date": "2013-05-10", "completion_date": "2016-07-28", "has_results": true, "last_update_posted_date": "2017-09-19", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 86, "location_summary": "Huntsville, Alabama • Los Alamitos, California • Mission Viejo, California + 83 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Riverside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01830543" }, { "nct_id": "NCT01078272", "title": "The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Remote ischemic preconditioning", "type": "OTHER" }, { "name": "Sham Remote Ischemic Preconditioning", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "St. Francis Hospital, New York", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 4, "start_date": "2010-03", "completion_date": "2011-10", "has_results": false, "last_update_posted_date": "2020-03-19", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 1, "location_summary": "Roslyn, New York", "locations": [ { "city": "Roslyn", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01078272" }, { "nct_id": "NCT05297812", "title": "Alpha-1 Antitrypsin Disease Cohort: Longitudinal Biomarker Study of Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alpha 1-Antitrypsin Deficiency", "Genetic Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 286, "start_date": "2022-03-23", "completion_date": "2027-01", "has_results": false, "last_update_posted_date": "2026-01-16", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 9, "location_summary": "Birmingham, Alabama • Los Angeles, California • Denver, Colorado + 6 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05297812" }, { "nct_id": "NCT03227588", "title": "Evaluation of the Opsens Fractional Flow Reserve (FFR) Wire as a \"Work Horse\" Wire", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Fractional Flow Reserve", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "Central Arkansas Veterans Healthcare System", "sponsor_class": "FED", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 1000, "start_date": "2017-04-10", "completion_date": "2019-12-10", "has_results": false, "last_update_posted_date": "2019-02-12", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 1, "location_summary": "Little Rock, Arkansas", "locations": [ { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03227588" }, { "nct_id": "NCT01916902", "title": "Effect of Pretreatment With Ticagrelor on Residual Thrombus After PCI in Patients Presenting With ACS in Comparison With Delayed Treatment at the Time of PCI: an OCT Study", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Acute Coronary Syndrome", "Coronary Artery Disease" ], "interventions": [ { "name": "Ticagrelor- Delayed Administration", "type": "DRUG" }, { "name": "Ticagrelor- Immediate Administration", "type": "DRUG" }, { "name": "Optical Coherence Tomography", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 0, "start_date": "2014-02", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-05-26", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01916902" }, { "nct_id": "NCT03988166", "title": "Chronic Total Occlusion Percutaneous Coronary Intervention Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Total Occlusion", "Ischemic Heart Disease", "Chronic Total Occlusion of Coronary Artery" ], "interventions": [ { "name": "Chronic Total Occlusion Revascularization", "type": "PROCEDURE" }, { "name": "GuideLiner® V3 catheter, TrapLiner® catheter, Turnpike® catheter", "type": "DEVICE" } ], "intervention_types": [ "PROCEDURE", "DEVICE" ], "sponsor": "Vascular Solutions LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2020-05-20", "completion_date": "2021-02-22", "has_results": true, "last_update_posted_date": "2022-09-28", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 13, "location_summary": "Torrance, California • Atlanta, Georgia • Boston, Massachusetts + 6 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03988166" }, { "nct_id": "NCT02956122", "title": "A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Graft Versus Host Disease" ], "interventions": [ { "name": "GLASSIA", "type": "BIOLOGICAL" }, { "name": "methylprednisolone or equivalent steroid", "type": "DRUG" }, { "name": "Albumin", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Baxalta now part of Shire", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1, "start_date": "2017-04-26", "completion_date": "2018-05-03", "has_results": true, "last_update_posted_date": "2021-01-13", "last_synced_at": "2026-10-23T06:51:29.584Z", "location_count": 1, "location_summary": "Augusta, Georgia", "locations": [ { "city": "Augusta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT02956122" } ] }